Literature DB >> 1389209

An antibody with specificity for surfactant protein C precursors: identification of pro-SP-C in rat lung.

M F Beers1, A Wali, M F Eckenhoff, S I Feinstein, J H Fisher, A B Fisher.   

Abstract

Surfactant protein C (SP-C) is a lung-specific, hydrophobic peptide found in organic extracts of pulmonary surfactant. Alveolar SP-C (3.5 kD) is produced from proteolytic cleavage of a larger precursor molecule (pro-SP-C; 21 kD). While SP-C is synthesized by type II cells, the pathways for processing and secretion have remained elusive due, in part, to the lack of monospecific antibodies against SP-C or its precursors. This report describes production and characterization of a new antibody directed against pro-SP-C epitopes. Polyclonal antisera (anti-CPRO-SP-C) was prepared using a synthetic peptide corresponding to a portion of rat SP-C cDNA sequence (Ile26-Ser72). This contained amino acids 3-35 of mature SP-C plus additional C-terminal residues (His59-Ser72). On Western blots, anti-CPRO-SP-C competitively reacted to CPRO-SP-C but not to mature SP-C. Immunoblots of in vitro synthesized pro-SP-C confirmed that the antisera also recognized native protein. Immunocytochemistry with anti-CPRO-SP-C demonstrated staining for pro-SP-C peptides in isolated type II cells as well as in alveolar epithelial cells of rat lung sections. Pro-SP-C preferentially co-localized to cells that stained positive for Maclura pomifera antigen. Anti-CPRO-SP-C staining was not observed in lung interstitium, pulmonary vasculature, or several control tissues (brain, heart, and liver were negative). Western blotting of subcellular fractions demonstrated pro-SP-C peptides in plasma membrane (20 kD) and microsomal (20 and 21 kD) fractions with a 16 kD peptide present in lamellar bodies. No pro-SP-C peptides were detected in purified surfactant. These results demonstrate the use of a synthetic peptide to generate specific antiserum against more hydrophilic domains of pro-SP-C sequences and confirm that SP-C propeptides are unique to the lung.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1389209     DOI: 10.1165/ajrcmb/7.4.368

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  9 in total

1.  Classical and alternative macrophage activation in the lung following ozone-induced oxidative stress.

Authors:  Vasanthi R Sunil; Kinal Patel-Vayas; Jianliang Shen; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2012-06-19       Impact factor: 4.219

Review 2.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

Review 3.  When Is an Alveolar Type 2 Cell an Alveolar Type 2 Cell? A Conundrum for Lung Stem Cell Biology and Regenerative Medicine.

Authors:  Michael F Beers; Yuben Moodley
Journal:  Am J Respir Cell Mol Biol       Date:  2017-07       Impact factor: 6.914

4.  Generation and characterization of a conditionally immortalized lung clara cell line from the H-2Kb-tsA58 transgenic mouse.

Authors:  Daphne E Demello; Sohir Mahmoud; Jan Ryerse; Joseph W Hoffmann
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-03       Impact factor: 2.416

5.  Endoderm development requires centrioles to restrain p53-mediated apoptosis in the absence of ERK activity.

Authors:  Chang Xie; Shaun R Abrams; Vicente Herranz-Pérez; Jose Manuel García-Verdugo; Jeremy F Reiter
Journal:  Dev Cell       Date:  2021-12-20       Impact factor: 12.270

6.  Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation.

Authors:  Elena N Atochina-Vasserman; Andrew J Gow; Helen Abramova; Chang-Jiang Guo; Yaniv Tomer; Angela M Preston; James M Beck; Michael F Beers
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

7.  Fatty diabetic lung: altered alveolar structure and surfactant protein expression.

Authors:  David J Foster; Priya Ravikumar; Dennis J Bellotto; Roger H Unger; Connie C W Hsia
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-01-08       Impact factor: 5.464

8.  Therapeutic lung lavages in children and adults.

Authors:  Christian Paschen; Karl Reiter; Franz Stanzel; Helmut Teschler; Matthias Griese
Journal:  Respir Res       Date:  2005-11-22

9.  Generation of an immortal differentiated lung type-II epithelial cell line from the adult H-2K(b)tsA58 transgenic mouse.

Authors:  D E deMello; S Mahmoud; P J Padfield; J W Hoffmann
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-06       Impact factor: 2.416

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.